ALNY in the 13F filings
Alnylam Pharmaceuticals Inc · CUSIP 02043Q107
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 8 May 2026
- Managers listing it
- 32
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 22 listed it in both
- Shares listed
- 54,535,745
- combined, among listed positions
- Reported value
- $18.0bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 16 buyers (opened or added shares) and 18 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -3,457,050.
Managers listing ALNY in Q1 2026
32 of 32 holders
Largest increases and reductions, by shares
Increases
- Capital Research Global Investorsexisting position · 9,471,181 shares now+2,691,473
- Two Sigma Investments LPexisting position · 1,992,577 shares now+1,376,457
- D. E. Shaw & Co.existing position · 1,059,062 shares now+614,569
- Marshall Wace LLPexisting position · 1,099,318 shares now+549,396
- Millennium Management LLCexisting position · 447,887 shares now+372,457
Reductions
- Capital World Investorsexisting position · 10,802,348 shares now-5,499,424
- Fidelity (FMR LLC)existing position · 14,579,166 shares now-1,322,983
- Invesco Ltdexisting position · 4,075,120 shares now-1,058,863
- Jane Street Group LLCexisting position · 5,902 shares now-305,386
- T. Rowe Price Associates Incexisting position · 1,432,748 shares now-270,083
New positions and exits
New (0)
No new position among listed positions.
Exited (2)
- Arrowstreet Capital LPwas $448m
- Balyasny Asset Management LLCwas $1.2m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 4 | $407m | n.a. | n.a. |
| Q3 2013 | 6 | $1.2bn | n.a. | n.a. |
| Q4 2013 | 7 | $1.5bn | n.a. | n.a. |
| Q1 2014 | 8 | $1.6bn | n.a. | n.a. |
| Q2 2014 | 6 | $1.7bn | n.a. | n.a. |
| Q3 2014 | 7 | $2.1bn | n.a. | n.a. |
| Q4 2014 | 6 | $2.2bn | n.a. | n.a. |
| Q1 2015 | 8 | $2.9bn | n.a. | n.a. |
| Q2 2015 | 6 | $3.3bn | n.a. | n.a. |
| Q3 2015 | 5 | $2.1bn | n.a. | n.a. |
| Q4 2015 | 6 | $2.7bn | n.a. | n.a. |
| Q1 2016 | 8 | $2.0bn | n.a. | n.a. |
| Q2 2016 | 7 | $2.0bn | n.a. | n.a. |
| Q3 2016 | 8 | $2.6bn | n.a. | n.a. |
| Q4 2016 | 8 | $1.6bn | n.a. | n.a. |
| Q1 2017 | 9 | $2.2bn | n.a. | n.a. |
| Q2 2017 | 14 | $3.8bn | n.a. | n.a. |
| Q3 2017 | 15 | $5.7bn | n.a. | n.a. |
| Q4 2017 | 14 | $6.3bn | n.a. | n.a. |
| Q1 2018 | 15 | $5.7bn | n.a. | n.a. |
| Q2 2018 | 15 | $4.4bn | n.a. | n.a. |
| Q3 2018 | 14 | $3.9bn | n.a. | n.a. |
| Q4 2018 | 10 | $3.3bn | n.a. | n.a. |
| Q1 2019 | 11 | $4.6bn | n.a. | n.a. |
| Q2 2019 | 16 | $3.8bn | n.a. | n.a. |
| Q3 2019 | 11 | $4.4bn | n.a. | n.a. |
| Q4 2019 | 13 | $6.2bn | n.a. | n.a. |
| Q1 2020 | 12 | $5.7bn | n.a. | n.a. |
| Q2 2020 | 15 | $7.7bn | n.a. | n.a. |
| Q3 2020 | 13 | $7.6bn | n.a. | n.a. |
| Q4 2020 | 13 | $6.5bn | n.a. | n.a. |
| Q1 2021 | 14 | $7.2bn | n.a. | n.a. |
| Q2 2021 | 13 | $8.8bn | n.a. | n.a. |
| Q3 2021 | 14 | $9.7bn | n.a. | n.a. |
| Q4 2021 | 12 | $8.8bn | n.a. | n.a. |
| Q1 2022 | 12 | $8.9bn | n.a. | n.a. |
| Q2 2022 | 13 | $8.1bn | n.a. | n.a. |
| Q3 2022 | 17 | $10.8bn | n.a. | n.a. |
| Q4 2022 | 16 | $13.7bn | n.a. | n.a. |
| Q1 2023 | 19 | $11.5bn | n.a. | n.a. |
| Q2 2023 | 16 | $10.6bn | n.a. | n.a. |
| Q3 2023 | 17 | $9.7bn | n.a. | n.a. |
| Q4 2023 | 15 | $10.0bn | 5 | 9 |
| Q1 2024 | 15 | $7.3bn | 10 | 6 |
| Q2 2024 | 19 | $12.5bn | 12 | 8 |
| Q3 2024 | 18 | $15.1bn | 7 | 11 |
| Q4 2024 | 15 | $12.8bn | 8 | 7 |
| Q1 2025 | 18 | $14.9bn | 11 | 7 |
| Q2 2025 | 22 | $18.3bn | 13 | 10 |
| Q3 2025 | 33 | $26.6bn | 25 | 8 |
| Q4 2025 | 24 | $23.4bn | 15 | 28 |
| Q1 2026 | 22 | $17.9bn | 16 | 18 |
| Q2 2026 | 21 | $15.9bn | 17 | 18 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ALNY and LLY →ALNY and JNJ →ALNY and VRTX →Choose a stock to compare with ALNY →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ALNY, latest filings →Back to the 13F Explorer →